Philip L McCarthy
Roswell Park Cancer Institute · Alliance for Clinical Trials in Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Philip L McCarthy as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03925532 · Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell TransplantRoswell Park Cancer Institute · completed · Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Osteopenia, Osteoporosis · principal investigator
- N/ANCT00534118 · Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantRoswell Park Cancer Institute · completed · Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm · principal investigator
- Ph3NCT00114101 · Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantNational Cancer Institute (NCI) · active not recruiting · DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma, DS Stage III Multiple Myeloma · principal investigator
- Ph1/Ph2NCT00003877 · Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast CancerRoswell Park Cancer Institute · completed · Breast Cancer · study chair
- Ph2NCT00060255 · High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsRoswell Park Cancer Institute · completed · Breast Cancer, Leukemia, Lymphoma · study chair
- N/ANCT00055666 · Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal TractRoswell Park Cancer Institute · completed · Graft Versus Host Disease · study chair
- Ph2NCT00055653 · Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersRoswell Park Cancer Institute · completed · Leukemia, Lymphoma, Myelodysplastic Syndromes · study chair
- Ph2NCT00053989 · NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRoswell Park Cancer Institute · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · principal investigator
- N/ANCT00053157 · Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic AnemiaRoswell Park Cancer Institute · completed · Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia · study chair
- Ph2/Ph3NCT00003816 · Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerRoswell Park Cancer Institute · completed · Chronic Myeloproliferative Disorders, Leukemia, Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT00114101
- Cancer and Leukemia Group BU10CA031946 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Monica M Bertagnolli · fiscal years 2012 to 2013Named on NCT00114101
- Administrative CoreP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dale Henry · fiscal years 2012 to 2026Named on NCT00003877
Most cited trial papers
Clinical-trial papers with this author name in multiple myeloma, ranked by citations from NIH iCite, fetched 2026-11-12 12:34 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Lenalidomide after stem-cell transplantation for multiple myeloma.N Engl J Med · 2012918 citationsRCR 24.3
- 433 citationsRCR 32.2
- 151 citationsRCR 4.7
- Comparison of twin and autologous transplants for multiple myeloma.Biol Blood Marrow Transplant · 200824 citationsRCR 0.5
- A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202).Am J Hematol · 202124 citationsRCR 1.1
- 17 citationsRCR 1.9
- Long-Term Follow-up of CALGB (Alliance) 100001: Autologous Followed by Nonmyeloablative Allogeneic Transplant for Multiple Myeloma.Biol Blood Marrow Transplant · 20206 citationsRCR 0.3